Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
If you are considering NK cell therapy in Japan, one of the first practical questions is what actually happens on the days you visit the clinic. Because the treatment uses your own cells, the process has a few distinct steps: a consultation, a blood draw, a period of cell processing, and then an intravenous infusion. This article walks through those steps at Grand Green Osaka Umekita Clinic in Osaka and lists questions worth asking, so you can plan with a clearer picture. It is general information, not medical advice.
The short answer: a blood draw, cell processing, then an infusion
In NK cell therapy, NK (natural killer) cells are obtained from a standard blood draw. The cells are then activated and expanded outside the body at a specialized, licensed cell processing facility. Later, the processed cells are returned to your body by intravenous infusion. The aim is to return NK cells that are greater in number and higher in activity, in the hope of reinforcing immune function.
There is no surgery involved, and the page describing the therapy at our clinic notes that no hospitalization is needed. That said, whether this therapy is appropriate for you, and how it fits with your other treatment, is a decision that depends on a doctor’s examination. No outcome can be promised.
Step one: the consultation before anything else
Treatment does not begin with a needle. It begins with a consultation, where a doctor reviews your medical history, your current or past cancer treatment, and your goals. This is also the time to ask about eligibility, expected costs, risks, and possible side effects. NK cell therapy is a self-pay treatment that is not covered by Japan’s public health insurance, so fees are something to understand clearly before you decide.
If you live abroad, it helps to bring a summary of your diagnosis and treatment in English, along with recent test results and a list of medicines you take. Your own oncologist may be able to provide this. NK cell therapy is described as something that can be used alongside surgery, chemotherapy, or radiation therapy, and the clinic can coordinate with the institution providing your standard treatment. Standard treatment remains the foundation, and NK cell therapy is not a substitute for it.
Step two: the blood draw day
On the blood draw day, a sample is taken in much the same way as a routine blood test. The sample is the starting material for your personalized cells, so it is handled as the first step of a manufacturing process rather than as a simple lab test. Staff will confirm your identity and explain how the sample is sent to the processing facility.
Questions you may want to ask on this day include:
- How much time should I allow for the visit?
- Is there anything I should avoid beforehand, such as certain medicines or activities?
- How will my sample be labeled and tracked so that the cells returned are my own?
- Is an interpreter or information in my language available?
Step three: waiting while the cells are activated and expanded
After the blood draw, there is a waiting period while your NK cells are activated and expanded. The length of this period and the scheduling of the infusion are matters to confirm directly with the clinic, because they depend on the treatment plan your doctor proposes. This is especially important if you are traveling from overseas, since you will need to arrange flights and accommodation around the schedule.
It is reasonable to ask how the processing facility is managed, and how quality is checked before cells are released. In Japan, cell therapies of this kind are provided under the Act on the Safety of Regenerative Medicine, which requires a provision plan to be submitted to and accepted by the authorities. Asking the clinic to explain this system, in plain language, is a sensible part of your preparation.
Step four: the infusion and what to expect afterward
On the infusion day, the processed NK cells are returned to your body through an IV drip, similar to receiving standard IV fluids. Because the therapy uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. However, temporary reactions such as fever or fatigue may occur, and individual responses vary. It is not accurate to describe any medical treatment as entirely free of risk.
Before you leave, ask what symptoms should prompt you to contact the clinic, and whom to call if you are back in your home country. Also ask whether a record of the treatment can be provided so that your regular doctor knows what you received. Clear communication between your doctors helps you make consistent decisions about your overall care.
Questions to bring to your Osaka consultation
Whether you live in Japan or are considering medical travel, writing your questions down in advance makes the consultation more productive. Useful topics include the following.
- Which parts of the process happen on which day, and how many visits are expected?
- What are the total fees, and what is included or not included?
- What are the known risks, side effects, and limits of the evidence for my situation?
- How will the therapy be coordinated with my current oncologist?
- What happens if my condition changes or I need to pause treatment?
The clinic in Osaka’s Umeda area offers information pages for international patients, so you can read about the therapy in English before you book. Use those pages to prepare, then rely on your doctor’s examination for decisions specific to you. Grand Green Osaka Umekita Clinic can explain the details of the treatment flow, costs, and risks during a consultation.
Key takeaways
NK cell therapy follows a clear sequence: consultation, blood draw, cell activation and expansion, and intravenous infusion. Each step raises practical questions about timing, fees, quality management, and coordination with your standard cancer treatment. Because the therapy is a self-pay treatment provided under Japan’s regenerative medicine framework, and because its suitability depends on your individual condition, a doctor’s consultation is the right place to confirm the details. Going in with a few well-prepared questions can help you weigh the option calmly and make a decision that fits your circumstances.
- 1ConsultationDoctor reviews your history
- 2Blood drawYour own cells are collected
- 3Cell expansionActivated outside the body
- 4IV infusionCells returned to you
This diagram is a conceptual summary of the article content
References
- PubMed: NK cells and ILCs in tumor immunotherapy. (2021)
- PubMed: Cell therapies in ovarian cancer. (2021)
- PubMed: The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. (2021)
- PubMed: Optimizing CAR-NK Cell Transduction and Expansion: Leveraging Cytokine Modulation for Enhanced Performance. (2024)
- PubMed: Challenges of cancer therapy with natural killer cells. (2015)
- PMC: Current progress in NK cell biology and NK cell-based cancer immunotherapy. (2020)
- PMC: Natural Killer Cell Recognition and Control of Epithelial Cancers. (2022)
- PMC: Advances in natural killer cell immunotherapy for hematologic malignancies. (2026)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.